What Does Metastatic Breast Cancer Mean to You?

Article

In this roundtable, representatives from Sharsheret, the Cancer Support Community, the Young Survival Coalition, and Living Beyond Breast Cancer discuss the impact of metastatic breast cancer.

In this roundtable, representatives from Sharsheret, the Cancer Support Community, the Young Survival Coalition, and Living Beyond Breast Cancer discuss the impact of metastatic breast cancer. The video is part of the Advocacy in Action: Young Women Living with Metastatic Breast Cancer initiative.

Related Videos
Pattie Jakel
Christine Wylie
Daly
Grace Choong
Ahulwalia on Targeting the Blood Brain Barrier With Novel Immunotherapies and Precision Oncology
Expert in oncology
Expert in oncology
Experts in oncology
Expert in oncology
Related Content
Preoperative Systemic Therapy May Improve Survival vs Mastectomy in HER2+ Breast Cancer

Preoperative Systemic Therapy May Improve Survival vs Mastectomy in HER2+ Breast Cancer

April 16th 2024
Article

Breast-conserving therapy following preoperative systemic therapy resulted in superior overall survival compared with mastectomy in patients with HER2-positive breast cancer.

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

October 2nd 2023
Podcast

Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.

FDA Accepts BLA for Dato-Dxd in HR+/HER2– Metastatic Breast Cancer

FDA Accepts BLA for Dato-Dxd in HR+/HER2– Metastatic Breast Cancer

April 3rd 2024
Article

The biologics license application for datopotamab deruxtecan has been accepted by the FDA for pretreated HR-positive, HER2-negative metastatic breast cancer.

The Vitals

Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium

January 16th 2023
Podcast

Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.

FDA Approves Fluorouracil Safety Label Update Regarding DPD Deficiency Use

FDA Approves Fluorouracil Safety Label Update Regarding DPD Deficiency Use

March 22nd 2024
Article

The safety label for fluorouracil products will now include information about the agent’s use in patients with dihydropyrimidine dehydrogenase deficiency.

Understanding the ‘Excitement’ Around ADCs for HR+/HER2– Breast Cancer

Understanding the ‘Excitement’ Around ADCs for HR+/HER2– Breast Cancer

March 13th 2024
Article

With the progress made with ADCs, there is interest in moving these agents up in the treatment paradigm for HR-positive/HER2-negative breast cancer.

© 2024 MJH Life Sciences

All rights reserved.